Literature DB >> 12126645

Activation of platelet caspases by TNF and its consequences for kinetics.

Pierre Francois Piguet1, Christian Vesin, Chen Da Kan.   

Abstract

TNF is known to induce a thrombocytopenia, due to a reduced platelet life span. Injection of TNF (10 microg) to mice did markedly increase the number of platelet-derived microparticles in plasma, most pronounced 1h after injection. Injection of TNF induced a transient activation of platelet caspases, -1, -3, -6, -8, -9, as seen by the binding of caspases probes detected by flow cytometry, most pronounced 1h after injection. Activation of caspase-3 was also evidenced by antibodies. Injection of the caspases inhibitor ZVAD-fmk decreased TNF-induced generation of microparticles and thrombocytopenia, indicating a causal role of caspases in platelet fragmentation. Activation of platelet caspases was also evident in platelets exposed to TNF in vitro, indicating that TNF acts on platelets directly. Comparison of platelets from +/+, TNFR1 -/- and TNFR2 -/- mice showed that caspases are activated mainly by the TNFR1. These observations indicate that TNF activates platelet caspases via the TNFR1, which results in platelet fragmentation and thrombocytopenia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12126645     DOI: 10.1006/cyto.2002.0889

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  9 in total

1.  Antithrombotic activity of TNF-alpha.

Authors:  Beatrice Cambien; Wolfgang Bergmeier; Simin Saffaripour; Heather A Mitchell; Denisa D Wagner
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

Review 2.  Bcl-3, a multifaceted modulator of NF-kappaB-mediated gene transcription.

Authors:  Scott Palmer; Youhai H Chen
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 3.  Human malarial disease: a consequence of inflammatory cytokine release.

Authors:  Ian A Clark; Alison C Budd; Lisa M Alleva; William B Cowden
Journal:  Malar J       Date:  2006-10-10       Impact factor: 2.979

4.  Pre-treatment whole blood gene expression is associated with 14-week response assessed by dynamic contrast enhanced magnetic resonance imaging in infliximab-treated rheumatoid arthritis patients.

Authors:  Kenzie D MacIsaac; Richard Baumgartner; Jia Kang; Andrey Loboda; Charles Peterfy; Julie DiCarlo; Jonathan Riek; Chan Beals
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

5.  Association between Inflammatory Cytokine Levels and Thrombocytopenia during Plasmodium falciparum and P. vivax Infections in South-Western Coastal Region of India.

Authors:  Kishore Punnath; Kiran K Dayanand; Valleesha N Chandrashekar; Rajeshwara N Achur; Srinivas B Kakkilaya; Susanta K Ghosh; Suchetha N Kumari; D Channe Gowda
Journal:  Malar Res Treat       Date:  2019-04-11

6.  Dynamics of Transforming Growth Factor (TGF)-β Superfamily Cytokine Induction During HIV-1 Infection Are Distinct From Other Innate Cytokines.

Authors:  Matthew Dickinson; Anna E Kliszczak; Eleni Giannoulatou; Dimitra Peppa; Pierre Pellegrino; Ian Williams; Hal Drakesmith; Persephone Borrow
Journal:  Front Immunol       Date:  2020-11-24       Impact factor: 7.561

7.  Elevated TNF-α Induces Thrombophagocytosis by Mononuclear Cells in ex vivo Whole-Blood Co-Culture with Dengue Virus.

Authors:  Rahmat Dani Satria; Ming-Kai Jhan; Chia-Ling Chen; Po-Chun Tseng; Yung-Ting Wang; Chiou-Feng Lin
Journal:  J Inflamm Res       Date:  2022-03-05

8.  Prothrombotic effects of tumor necrosis factor alpha in vivo are amplified by the absence of TNF-alpha receptor subtype 1 and require TNF-alpha receptor subtype 2.

Authors:  Joachim Pircher; Monika Merkle; Markus Wörnle; Andrea Ribeiro; Thomas Czermak; Yvonn Stampnik; Hanna Mannell; Markus Niemeyer; Volker Vielhauer; Florian Krötz
Journal:  Arthritis Res Ther       Date:  2012-10-18       Impact factor: 5.156

9.  Platelet dysfunction in injured patients.

Authors:  Noelle N Saillant; Carrie A Sims
Journal:  Mol Cell Ther       Date:  2014-12-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.